BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 31964553)

  • 1. TPK1 as a predictive marker for the anti-tumour effects of simvastatin in gastric cancer.
    Hong JY; Kim HJ; Kim K; Hong J; Kim JE; Byeon SJ; Lee IK; Kim KM; Shim M; Park SH; Park JO; Park YS; Lim HY; Kim ST; Lee J; Kang WK
    Pathol Res Pract; 2020 Mar; 216(3):152820. PubMed ID: 31964553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
    Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
    Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a.
    Wolfe AR; Debeb BG; Lacerda L; Larson R; Bambhroliya A; Huang X; Bertucci F; Finetti P; Birnbaum D; Van Laere S; Diagaradjan P; Ruffell B; Trenton NJ; Chu K; Hittelman W; Diehl M; Levental I; Ueno NT; Woodward WA
    Breast Cancer Res Treat; 2015 Dec; 154(3):495-508. PubMed ID: 26590814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of 3-hydroxy-3-methylglutaryl-CoA reductase mediates statin resistance in breast cancer cells.
    Göbel A; Breining D; Rauner M; Hofbauer LC; Rachner TD
    Cell Death Dis; 2019 Jan; 10(2):91. PubMed ID: 30692522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mitochondrial DNA mutation influences the apoptotic effect of statins on prostate cancer.
    Sun Q; Arnold RS; Sun CQ; Petros JA
    Prostate; 2015 Dec; 75(16):1916-25. PubMed ID: 26383260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression.
    Kochuparambil ST; Al-Husein B; Goc A; Soliman S; Somanath PR
    J Pharmacol Exp Ther; 2011 Feb; 336(2):496-505. PubMed ID: 21059805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin exhibits antiproliferative effects on spheres derived from canine mammary carcinoma cells.
    Torres CG; Olivares A; Stoore C
    Oncol Rep; 2015 May; 33(5):2235-44. PubMed ID: 25778435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin and atorvastatin as inhibitors of proliferation and inducers of apoptosis in human cholangiocarcinoma cells.
    Buranrat B; Senggunprai L; Prawan A; Kukongviriyapan V
    Life Sci; 2016 May; 153():41-9. PubMed ID: 27098189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of simvastatin-induced apoptosis and cell cycle arrest in cancer stem cells of MCF-7.
    Afzali M; Vatankhah M; Ostad SN
    J Cancer Res Ther; 2016; 12(2):725-30. PubMed ID: 27461641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin suppresses the DNA replication licensing factor MCM7 and inhibits the growth of tamoxifen-resistant breast cancer cells.
    Liang Z; Li W; Liu J; Li J; He F; Jiang Y; Yang L; Li P; Wang B; Wang Y; Ren Y; Yang J; Luo Z; Vaziri C; Liu P
    Sci Rep; 2017 Feb; 7():41776. PubMed ID: 28150753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of the anticancer effect of doxorubicinin drug-resistant gastric cancer cells by tanshinone IIA.
    Xu Z; Chen L; Xiao Z; Zhu Y; Jiang H; Jin Y; Gu C; Wu Y; Wang L; Zhang W; Zuo J; Zhou D; Luan J; Shen J
    Phytomedicine; 2018 Dec; 51():58-67. PubMed ID: 30466628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG-CoA reductase inhibitor simvastatin overcomes bortezomib-induced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway.
    Fuchs D; Berges C; Opelz G; Daniel V; Naujokat C
    Biochem Biophys Res Commun; 2008 Sep; 374(2):309-14. PubMed ID: 18625202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin-mediated reduction of osteopontin expression induces apoptosis and cell growth arrest in ovarian clear cell carcinoma.
    Matsuura M; Suzuki T; Suzuki M; Tanaka R; Ito E; Saito T
    Oncol Rep; 2011 Jan; 25(1):41-7. PubMed ID: 21109955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells.
    Miyazawa Y; Sekine Y; Kato H; Furuya Y; Koike H; Suzuki K
    Prostate; 2017 Mar; 77(4):337-349. PubMed ID: 27862098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer.
    Stine JE; Guo H; Sheng X; Han X; Schointuch MN; Gilliam TP; Gehrig PA; Zhou C; Bae-Jump VL
    Oncotarget; 2016 Jan; 7(1):946-60. PubMed ID: 26503475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway.
    Kodach LL; Jacobs RJ; Voorneveld PW; Wildenberg ME; Verspaget HW; van Wezel T; Morreau H; Hommes DW; Peppelenbosch MP; van den Brink GR; Hardwick JC
    Gut; 2011 Nov; 60(11):1544-53. PubMed ID: 21551187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor.
    Sekine Y; Furuya Y; Nishii M; Koike H; Matsui H; Suzuki K
    Biochem Biophys Res Commun; 2008 Jul; 372(2):356-61. PubMed ID: 18489904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of simvastatin on the resistance to EGFR tyrosine kinase inhibitors in a non-small cell lung cancer with the T790M mutation of EGFR.
    Hwang KE; Kwon SJ; Kim YS; Park DS; Kim BR; Yoon KH; Jeong ET; Kim HR
    Exp Cell Res; 2014 May; 323(2):288-96. PubMed ID: 24631288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin induces heme oxygenase-1 via NF-E2-related factor 2 (Nrf2) activation through ERK and PI3K/Akt pathway in colon cancer.
    Jang HJ; Hong EM; Kim M; Kim JH; Jang J; Park SW; Byun HW; Koh DH; Choi MH; Kae SH; Lee J
    Oncotarget; 2016 Jul; 7(29):46219-46229. PubMed ID: 27323826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Barret's adenocarcinoma cell growth by simvastatin: involvement of COX-2 and apoptosis-related proteins.
    Konturek PC; Burnat G; Hahn EG
    J Physiol Pharmacol; 2007 Aug; 58 Suppl 3():141-8. PubMed ID: 17901590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.